SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001354488-16-006547
Filing Date
2016-03-14
Accepted
2016-03-14 16:31:49
Documents
87
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tenx_10kt.htm 10-KT 2324257
2 CONSENT tenx_ex231.htm EX-23.1 4666
3 CERTIFICATION tenx_ex311.htm EX-31.1 11632
4 CERTIFICATION tenx_ex312.htm EX-31.2 11647
5 CERTIFICATION tenx_ex321.htm EX-32.1 7837
6 CERTIFICATION tenx_ex322.htm EX-32.2 8491
7 FIRST AMENDMENT TO LEASE AGREEMENT FOR NORTH CAROLINA CORPORATE OFFICE tenx_ex1074.htm EX-10.74 105610
8 img01.jpg GRAPHIC 65259
9 figure1.jpg GRAPHIC 108790
10 figureb.jpg GRAPHIC 195218
  Complete submission text file 0001354488-16-006547.txt   8894779

Data Files

Seq Description Document Type Size
11 tenx-20151231.xml EX-101.INS 1913917
12 tenx-20151231.xsd EX-101.SCH 64312
13 tenx-20151231_cal.xml EX-101.CAL 54669
14 tenx-20151231_def.xml EX-101.DEF 133023
15 tenx-20151231_lab.xml EX-101.LAB 455442
16 tenx-20151231_pre.xml EX-101.PRE 296224
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 001-34600 | Film No.: 161504230
SIC: 8731 Services-Commercial Physical & Biological Research